Abstract
The review focused on the development of utilizing photodynamic therapy (PDT) in skin diseases in Taiwan is presented. PDT uses a sensitizer, light and molecular oxygen to selectively kill cells. The use of 5-aminolevulinic acid (ALA) as photosensitizing prodrug to treat patients with basal cell carcinoma, Bowen's disease and actinic keratosis was begun in 1998. PDT could also improve wound healing in patients with chronic infected wounds.
| Original language | English |
|---|---|
| Title of host publication | Second Asian and Pacific Rim Symposium on Biophotonics - Proceedings, APBP 2004 |
| Pages | 70-71 |
| Number of pages | 2 |
| Publication status | Published - 2004 |
| Event | Second Asian and Pacific Rim Symposium on Biophotonics, APBP 2004 - Taipei, Taiwan Duration: 2004 Dec 15 → 2004 Dec 17 |
Publication series
| Name | Second Asian and Pacific Rim Symposium on Biophotonics - Proceedings, APBP 2004 |
|---|
Other
| Other | Second Asian and Pacific Rim Symposium on Biophotonics, APBP 2004 |
|---|---|
| Country/Territory | Taiwan |
| City | Taipei |
| Period | 04-12-15 → 04-12-17 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Engineering
Fingerprint
Dive into the research topics of 'Photodynamic therapy in dermatology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver